About Juniper Genomics
Juniper Genomics was founded in 2020 in Toronto, Canada. Services in the reproductive genomics sector are offered, focusing on embryo testing to enhance IVF outcomes. Whole genome and transcriptome sequencing is employed, integrated with proprietary algorithms for data analysis and success prediction. This process is applied to embryo datasets to support first-transfer decisions, operating within the biotech field to address IVF challenges.
- Headquarter Toronto, Canada
- Founders Trisha Convery, Jeremy Grushcow, Carolyn Quinlan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Juniper Genomics
Detailed funding history for Juniper Genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Juniper Genomics
Investment portfolio details for Juniper Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Juniper Genomics
Detailed financials for Juniper Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Juniper Genomics Comparisons
Peer comparison for Juniper Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Juniper Genomics
Detailed competitors of Juniper Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Juniper Genomics
Complete news archive for Juniper Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juniper Genomics
Juniper Genomics was founded in 2020.
Juniper Genomics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Jeremy Grushcow is the current CEO of Juniper Genomics. They have also founded this company.
Juniper Genomics was founded in 2020 in Toronto, Canada. Services in the reproductive genomics sector are offered, focusing on embryo testing to enhance IVF outcomes. Whole genome and transcriptome sequencing is employed, integrated with proprietary algorithms for data analysis and success prediction. This process is applied to embryo datasets to support first-transfer decisions, operating within the biotech field to address IVF challenges.